Thirona secures patent to implement AI for the early detection of cystic fibrosis patients

The AI medical image analysis company, which focuses on respiratory conditions, earned a license permitting it to develop an AI tool to analyze lung scans and more efficiently detect the progression of cystic fibrosis (CF) in children, according to MobiHealthNews. Thirona’s LungQ software will help clinicians detect and determine the extent of CF lung disease. CF is a rare condition without a cure that affects 70,000 patients globally—most of whom are diagnosed in early childhood.

As seen in:

Business Insider



View Project

Oshine - Model Agency

Award winning Model Agency based out of Paris.

Visit Us

Level 6 Spaces Business Center,
Downtown, London – 12345

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Consent to display content from Youtube
Consent to display content from Vimeo
Google Maps
Consent to display content from Google